Heart Failure Beat: Get with the Guidelines! Contemporary Heart Failure Clinical Practice Updates from HFSA: Devices, Cardio-Oncology, and Palliative Care
This episode highlights critical updates in heart failure care with insights from leading experts. First, Marat Fudim, MD, MHS discusses the HFSA statement on device-based therapies, including emerging innovations like cardiac contractility modulation and remote monitoring tools. Next, Michelle Weisfelner Bloom, MD and Ana Barac, MD, PhD present the groundbreaking cardio-oncology and heart failure scientific statement, emphasizing the integration of cancer therapies and heart care. They explore strategies to manage treatment-related cardiac dysfunction and propose a "permissive toxicity" framework. Finally, Sarah Chuzi, MD, MSc and Haider Warraich, MD detail HFSA's palliative care consensus statement, providing actionable guidance for integrating primary and specialty palliative care in heart failure management. This episode equips clinicians with practical strategies and a forward-looking perspective to enhance patient outcomes.
Listen below and subscribe: Apple Podcasts, Amazon Music, Spotify, Podcast Home
Chapters and Guests:
Chapter 1: Device Based Therapies with Michael and Guest
-
1:25-17:30 HFSA Scientific Statement: Update on Device Based Therapies in Heart Failure
- Marat Fudim, MD, MHS Heart Failure Cardiologist at Duke University Medical Center
- View Quick Highlights and Top 10 Takeaways >>
Chapter 2: Cardio-Oncology with Priya and Guests
-
17:30-32:55 Cardio-Oncology and Heart Failure: A Scientific Statement from the Heart Failure Society of America
-
Ana Barac, MD, Medical Director of the Cardio-Oncology Program at the Inova Schar Heart and Vascular, Inova Schar Cancer, Falls Church, Virginia
-
Michelle Bloom, MD, Advanced Heart Failure Cardiologist and Cardio-Oncologist at the Division of Cardiology, NYU Langone Health, NYU Grossman School of Medicine, New York, NY)
-
Chapter 3: Palliative Care with Michael and Guests
-
-
Sarah Chuzi, MD, MSc, Northwestern University Feinberg School of Medicine, Chicago, IL
-
Haider Warraich, MD, Senior Clinical Advisor for Chronic Disease to the FDA Commissioner
-
